Company / CapEx per Share
Olema Pharmaceuticals, Inc. CapEx per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2024
5-year range
$0.00 / $0.04
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#155 of 192
Health Care
What the data says
Olema Pharmaceuticals, Inc.'s capex per share of $0.00 is lower than 81% of companies in the Health Care sector (FY2024). Declined from $0.04 to $0.00 over the past 3 years.
Based on SEC 10-K filings.
0.00 in FY2024 with a 3-year CAGR of -59.2%.
Declined from $0.04 to $0.00 over the past 3 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -59.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 192This company $0.00 Sector average $3.54
▼
-99.9% below sector average
Key checks
Key Insights
- Ranks #155 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | - |
| FY2023 | - | - |
| FY2022 | $0.01 | -77.2% |
| FY2021 | $0.04 | +399.6% |
| FY2020 | $0.01 | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026